Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects - 2Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- 3Virtual reality opens doors for older people to build closer connections in real life
- 4Instructions to Upgrade the Security Elements of Your Kona SUV
- 5Dominating the Art of Composing: Creator Bits of knowledge
- Vote In favor of Your Favored Shimmering Water
- Israeli president concerned over proposed renaming of park
- What really happens when 140 reality stars come face to face with their biggest fans
- In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
- Misjudged Objections For Solo Voyagers
- Discovering a true sense of harmony: Contemplation and Care Practices
- Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- Iran, Hezbollah fire rockets at Israel during Passover celebrations
- Solid Living Tips: Experiences from a Wellness Fan
